⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10187702 | 0.87 | — | — | |
| SCHEMBL8471500 | 0.81 | KDM4E (0.31) | — | |
| SCHEMBL441721 | 0.79 | — | — | |
| Fluoride SCHEMBL28317530 | 0.78 | — | — | |
| SCHEMBL16297795 | 0.77 | — | — | |
| SCHEMBL8480452 | 0.74 | KDM4E (0.31) | — | |
| SCHEMBL5432 | 0.73 | — | — | |
| SCHEMBL8397539 | 0.73 | — | — | |
| SCHEMBL23229930 | 0.73 | MEN1 (0.43) | — | |
| Isobutane SCHEMBL586014 | 0.72 | LMNA (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138998-A1 | GLP-1 RECEPTOR AGONISTS AND METHODS OF USE | MERCK SHARP & DOHME LLC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260109715-A1 | IMIDAZOPYRIDINE DERIVATIVES WITH BICYCLIC STRUCTURE | PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4674879-A1 | CATIONIC POLYMERIZATION INITIATOR COMPOSITION, AND METHOD FOR PRODUCING OXYMETHYLENE COPOLYMER AND MOLDED ARTICLE USING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-12398136-B2 | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors | VENTUS THERAPEUTICS U.S., INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-12331048-B2 | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors | VENTUS THERAPEUTICS U.S., INC. (US) | 2025-06-17 | — | — | US | disclosed |
| US-20250002479-A1 | PYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2025-01-02 | — | — | US | disclosed |
| US-12172984-B2 | Pyrazolopyridine derivatives and uses thereof | NOVARTIS AG (CH) | 2024-12-24 | — | — | US | disclosed |
| US-20240409540-A1 | PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS | VENTUS THERAPEUTICS U S INC (US) | 2024-12-12 | — | — | US | disclosed |
| US-20240383896-A1 | PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS | VENTUS THERAPEUTICS U.S., INC. | 2024-11-21 | — | — | US | disclosed |
| US-20240382457-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | NOVARTIS PHARMA AG (CH) | 2024-11-21 | — | — | US | disclosed |
| US-20070049536-A1 | Novel compounds as inhibitors of hepatitis C virus NS3 serine protease | SCHERING CORPORATION | 2007-03-01 | — | — | US | disclosed |
| US-7183293-B2 | Ether derivatives useful as inhibitors of PDE4 isozymes | PFIZER INC. (US) | 2007-02-27 | — | — | US | disclosed |
| US-20070042968-A1 | Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease | SCHERING CORPORATION | 2007-02-22 | — | — | US | disclosed |
| US-20070032433-A1 | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION CORVAS INTERNATIONAL, LTD. | 2007-02-08 | — | — | US | disclosed |
| US-20070010453-A1 | Prodrugs of GABA analogs, compositions and uses thereof | XENOPORT, INC. | 2007-01-11 | — | — | US | disclosed |
| US-20070010453-A1 | Prodrugs of GABA analogs, compositions and uses thereof | XENOPORT, INC. | 2007-01-11 | — | — | US | disclosed |
| WO-2006113942-A2 | METHOD OF INHIBITING CATHEPSIN ACTIVITY | SCHERING CORPORATION (US) | 2006-10-26 | — | — | WO | disclosed |
| US-20040077553-A1 | Prodrugs of GABA analogs, compositions and uses thereof | XENOPORT, INC. | 2004-04-22 | — | — | US | disclosed |
| CN-1114599-C | Process for preparing dihydropyrane compound | KAO CORP (JP) | 2003-07-16 | — | — | CN | disclosed |
| CN-1180701-A | Process for preparing dihydropyrane compound | KAO CORP (JP) | 1998-05-06 | — | — | CN | disclosed |